Codexis, Inc. (CDXS) Cash Flow Statement

NASDAQ: CDXSOperating cash, capex, free cash flow and buybacks.

Where CDXS’s cash came from and went, 2025

December 31, 2025 · U.S. dollars
Cash from operations
−$19.4M
Capital expenditures
$4.5M
6.4% of revenue
Free cash flow
−$23.8M
−33.9% margin
Returned to shareholders
—
Change in cash
$32.1M
cash at year-end $52.9M
Investments (net): $28.0MInvestments (net)$28.0MBorrowing: $9.9MBorrowing$9.9MShares issued: $17.3MShares issued$17.3MOther financing: $764,000Other financing$764,000Cash used in operations: $19.4MCash used in operations$19.4M · 35%Capital expenditures: $4.5MCapital expenditures$4.5M · 8%Added to cash: $32.1MAdded to cash$32.1M · 57%$55.9M
Cash from operations
−$19.4M
Capital expenditures
−$4.5M
Investments (net)
+$28.0M
Net borrowing (repayment)
+$9.9M
Shares issued
+$17.3M
Other financing
+$764,000
Change in cash
$32.1M

Drawn to scale: where the cash came from and how it was used. Hover for values.

CDXS operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

CDXS cash flow trends, 2016–2025

Codexis, Inc. cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$2.7M2016−$19.4M2025—
Capital expenditures$888,0002016$4.5M2025+19.7%/yr
Free cash flow−$3.6M2016−$23.8M2025—
Free cash flow margin−7.3%2016−33.9%2025−26.5 pts
Stock-based compensation$5.7M2016$9.6M2025+6.0%/yr
Dividends paid$02016$1.3M2020—
Share buybacks (net)$1.5M2016$404,0002023−17.3%/yr
Capex / revenue1.8%20166.4%2025+4.5 pts

Change is the average annual growth (CAGR) or the difference between the first and latest year.

CDXS cash flow by activity

OperatingInvestingFinancingChange in cash

CDXS net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

CDXS cash flow statement

Codexis, Inc. annual cash flow statement
2025202420232022202120202019201820172016
Operating activities
Net income−$44.0M−$65.3M−$76.2M−$33.6M−$21.3M−$24.0M−$11.9M−$10.9M−$23.0M−$8.6M
Depreciation & amortization$5.2M$4.9M$9.9M$10.3M$5.9M$4.6M$4.6M$1.1M$1.0M$4.5M
Stock-based compensation$9.6M$13.1M$10.0M$14.5M$11.6M$7.7M$6.9M$7.9M$7.1M$5.7M
Change in working capital$6.4M−$12.0M−$18.2M$21.6M−$7.6M−$3.9M−$12.7M−$12.3M$6.3M−$4.3M
Other non-cash items$3.3M$9.8M$21.9M−$1.5M−$2.9M−$845,000$525,000$91,000−$198,000−$42,000
Cash from operating activities−$19.4M−$49.4M−$52.6M$11.3M−$14.3M−$16.5M−$12.6M−$14.1M−$8.8M−$2.7M
Investing activities
Capital expenditures−$4.5M−$4.3M−$4.4M−$8.3M−$13.8M−$3.7M−$3.7M−$2.8M−$985,000−$888,000
Investments (net)$28.0M−$57.0M−$5.9M−$13.6M−$7.6M−$2.0M$62,000−$2.8M−$908,000−$842,000
Acquisitions & other investing$5,000$4.3M$5.5M$8.3M$36,000$0$3,000$2.8M$985,000$888,000
Cash from investing activities$23.5M−$57.0M−$4.9M−$13.6M−$21.4M−$5.7M−$3.7M−$2.8M−$908,000−$842,000
Financing activities
Dividends paid—————−$1.3M−$2.9M—$0$0
Share repurchases & issuance (net)——−$404,000−$1.5M−$1.2M−$1.3M−$2.9M−$3.2M−$1.7M−$1.5M
Net borrowing (repayment)$9.9M$29.5M$0$0$0−$60,000−$242,000−$238,000−$175,000−$175,000
Shares issued$17.3M$31.3M$8.7M$1.5M$0$86.2M$50.0M$37.5M$0$0
Other financing$764,000−$318,000−$81,000−$627,000$5.0M−$2.9M$9.9M$4.5M$23.5M$1.2M
Cash from financing activities$27.9M$60.5M$8.2M−$575,000$3.8M$80.8M$54.0M$38.6M$21.6M−$490,000
Summary
Net change in cash$32.1M−$45.9M−$49.3M−$2.9M−$31.9M$58.6M$37.7M$21.7M$12.0M−$4.0M
Cash at end of period$52.9M$20.8M$66.7M$116.0M$118.9M$150.8M$92.2M$54.5M$31.2M$19.2M
Free cash flow−$23.8M−$53.7M−$57.1M$3.0M−$28.1M−$20.2M−$16.3M−$16.9M−$9.7M−$3.6M
Free cash flow margin−33.9%−90.5%−81.3%2.1%−26.8%−29.3%−23.8%−27.8%−19.5%−7.3%
Capex / revenue6.4%7.3%6.3%6.0%13.2%5.4%5.4%4.6%2.0%1.8%

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

CDXS cash generation

In fiscal 2025 (ended December 31, 2025), Codexis generated -$19.4 million of cash from operations and spent $4.5 million on capital expenditures, leaving free cash flow of -$23.8 million, −33.9% of revenue. Cash and equivalents rose by $32.1 million over the year.

Related: CDXS income statement, CDXS balance sheet. See the CDXS stock overview for the latest quote and news.

CDXS cash flow FAQ

What is Codexis's free cash flow?

Codexis's free cash flow was -$23.8 million in fiscal 2025: -$19.4 million of operating cash flow minus $4.5 million of capital expenditures It was -$53.7 million a year earlier..

How much cash does Codexis generate from operations?

Codexis generated -$19.4 million of cash from operating activities in fiscal 2025.

How much does Codexis spend on capital expenditures?

Codexis spent $4.5 million on capital expenditures in fiscal 2025, 6.4% of revenue, compared with $4.3 million the year before.

Biotechnology: cash flow